Related Experiment Video
Updated: Mar 24, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Treatment motivation in patients with chronic cardiorenal syndrome]
E V Efremova1, A M Shutov1, E O Borodulina1
1Institute of Medicine, Ecology, and Physical Education, Ulyanovsk State University, Ministry of Health of Russia, Ulyanovsk, Russia.
Insights
Patients with chronic cardiorenal syndrome (CRS) show low treatment motivation. Co-existing chronic kidney disease (CKD) worsens heart failure (CHF) and psychological well-being, impacting adherence to therapies.
Area of Science:
- Cardiology
- Nephrology
- Psychology
Context:
- Chronic heart failure (CHF) management is complex.
- Concurrent chronic kidney disease (CKD) in CHF patients, termed cardiorenal syndrome (CRS), presents unique challenges.
- Understanding patient motivation is crucial for effective treatment adherence.
Purpose:
- To investigate treatment motivation in patients with CHF.
- To compare motivation levels between patients with CHF alone and those with CHF and concurrent CKD (CRS).
- To identify psychological factors influencing treatment motivation in CRS patients.
Summary:
- A study of 203 patients with CHF, including 89 with concurrent CKD (CRS), revealed inadequate treatment motivation in 84.7% of all CHF patients.
- Patients with CRS exhibited higher anxiety and maladaptive disease attitudes compared to those with CHF alone.
- Low motivation in CRS patients was linked to euphoric attitudes towards their disease, while satisfactory motivation correlated with emotive character accentuation.
Impact:
- CKD significantly worsens the clinical course of CHF and negatively impacts patient psychological functioning.
- CRS patients demonstrate a low motivation for both drug and non-drug treatments.
- Findings necessitate tailored management strategies for CRS patients to improve treatment adherence and outcomes.
Aim:
To study treatment motivation in patients with chronic heart failure (CHF) and in those with CHF concurrent with chronic kidney disease (CKD).
Subjects And Methods:
A total of 203 patients (130 men and 73 women; mean age, 61.8±9.6 years) with CHF diagnosed and assessed in accordance with the National Guidelines of the All-Russian Research Society of Cardiology and the Heart Failure Society for the diagnosis and treatment of CHF (third edition, 2009) were examined. CKD was diagnosed according to the 2012 National Guidelines of the Research Nephrology Society of Russia. A group of patients with chronic cardiorenal syndrome (CRS) included those with CHF and CKD with a glomerular filtration rate (GFR) of <60 ml/min/1.73 m2. The clinical course of CHF, personality profile, and motivation for non-drug and drug treatments were assessed in patients with chronic CRS.
Results:
CFR was 67.7±17.2 ml/min/1.73 m2; chronic CRS was observed in 89 (44%) patients. Psychological functioning assessment showed that the patients with chronic CRS as compared with those with CHF without CKD had high anxiety and maladaptive disease attitudes. CHF treatment motivation (compliance with lifestyle modification and medication) was proved inadequate and detected only in 31 (15.3%) patients with CHF regardless of the presence of CKD. The specific features of psychological functioning, which affected treatment motivation, were seen in patients with chronic CRS: those who were lowly motivated had a euphoric attitude towards their disease (p=0.03); those who were satisfactorily motivated showed an emotive accentuation of character (p=0.002).
Conclusion:
The presence of CKD aggravates the clinical course of CHF and negatively affects the psychological functioning of patients with CHF. The patients with chronic CRS are characterized by a low level of motivation for both drug and non-drug treatments, which should be taken into account when managing this cohort of patients.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure VI: Adjunct Therapies
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Heart Failure V: Medical Management
Heart Failure Drugs: Diuretics

